Learning Optimal Group-structured Individualized Treatment Rules with Many Treatments

Area of Science:

• Machine Learning
• Biostatistics
• Personalized Medicine

Background:

• Individualized Treatment Rules (ITRs) aim to maximize expected outcomes by tailoring decisions to patient characteristics.
• Existing methods for ITRs often struggle with a large number of treatment options or fail to leverage treatment effect structures.
• The complexity increases significantly as the number of treatment arms grows, limiting the effectiveness of current approaches.

Purpose of the Study:

• To propose a novel method, GRoup Outcome Weighted Learning (GROWL), for estimating optimal group-structured ITRs.
• To address the challenge of decision-making with a large number of treatment arms by uncovering latent structures.
• To provide theoretical guarantees and demonstrate superior performance compared to existing methods.

Main Methods:

• GROWL integrates the estimation of treatment group structure and optimal group-structured ITRs within a single optimization framework.
• Utilizes Reinforced Angle based Multicategory Support Vector Machines (RAMSVM) for learning group-based decision rules.
• Employs a weighted angle-based multi-class classification framework for robust group-based decision rule learning.

Main Results:

• Theoretical guarantees, including Fisher consistency, excess risk bounds, and convergence rates for the value function, are established for GROWL.
• Simulation studies demonstrated GROWL's effectiveness in handling complex treatment structures.
• Real-world data analysis confirmed GROWL's superior performance over several existing ITR estimation methods.

Conclusions:

• GROWL offers a robust and theoretically sound approach for developing optimal group-structured ITRs, particularly when dealing with numerous treatment options.
• The method's ability to estimate latent treatment structures enhances decision-making accuracy in personalized medicine.
• GROWL represents a significant advancement in data-driven individualized decision-making for complex treatment scenarios.